Advanced Nanotechnology‐Driven Innovations for Corneal Neovascularization Therapy: Smart Drug Delivery and Enhanced Treatment Strategies (Adv. Mater. 43/2025)
Corneal Neovascularization Therapy ln their Review (DOI: 10.1002/adma.202508726), Wei Tao, Xingtao Zhou, Mei Yang, Jinhai Huang, and co-workers assess recent nanotechnology-driven advances in corneal neovascularization (CoNV) therapy. The cover image metaphorically represents a bright path to healing CoNV via nanorobots. They clear the inflammation (symbolized by rain), repair the cornea, and prune the neovascularization (vines), restoring clear vision and guiding toward a brighter future.
Authors
- Yue Wu (ORCID: https://orcid.org/0000-0003-1974-095X)
- Jinhai Huang (ORCID: https://orcid.org/0000-0001-9952-3175)
- Xiaomin Huang (ORCID: https://orcid.org/0009-0003-3524-3758)
- Wenqian Xing
- Zhongxing Chen (ORCID: https://orcid.org/0000-0001-8445-4410)
- Kexin Li (ORCID: https://orcid.org/0000-0001-6490-1332)
- Wei Tao (ORCID: https://orcid.org/0000-0002-4277-3728)
- Xingtao Zhou (ORCID: https://orcid.org/0000-0003-4236-2889)
- Nan Zhao (ORCID: https://orcid.org/0000-0001-5153-4908)
- Mei Yang (ORCID: https://orcid.org/0000-0002-9524-3018)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Eye & ENT Hospital of Fudan University (CN)
Publication Details
- Journal
- Advanced Materials
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/adma.70846
- Primary Topic
- Corneal Surgery and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00